Marital Status and Fertility in Adult Iranian Patients with β-Thalassemia Major
Tóm tắt
Expecting a family is an important component and a great goal for better quality of life for most of adults with β-thalassemia major. The aim of the present study was to examine the marital status of adults with β-thalassemia major. This cross-sectional study examined the marital status of patients with transfusion-dependent β-thalassemia aged over 15 years. Patients’ demographic characteristics including age, gender, marital status, duration of marriage, divorce, having or not having children and spouse’s health status were recorded. Information about the disease including cardiac and endocrine complications, ferritin level, splenectomy and viral hepatitis were also recorded. Of 228 patients with transfusion-dependent β-thalassemia major aged over 15 years who were treated at this medical center, 32 (14 %) were married. The mean age of married patients was 25.18 ± 4.74 years. Among the married patients, 8 (25 %) were females and 24 (75 %) patients were males. The mean age of marriage was 22.76 ± 4.16 years. The minimum and maximum marriage age was 15 and 33 years, respectively. The median duration of marriage was one year with the range from 3 months to 11 years. Only 8 (25 %) patients (one female and seven males) had children. Therapeutic advances have led to significantly increased survival and improved quality of life and fertility of patients with β-thalassemia major. According to the results, 14 % of patients over 15 years were married which was slightly higher as compared with other similar studies.
Tài liệu tham khảo
Cunningham MJ (2010) Update on thalassemia: clinical care and complications. Hematol Oncol Clin North Am 24(1):215–227
Ismail A, Campbell MJ, Ibrahim HM, Jones GL (2006) Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes 4:39
Weatherall D (2004) 2003 William Allan Award address. The Thalassemias the role of molecular genetics in an evolving global health problem. Am J Hum Genet 74(3):385–392
Angastiniotis M, Modell B (1998) Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 850:251–269
Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Psiloines M, Simamonian K, Skordos G, Sitarou M, Angastiniotis M (2006) Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Hematologica 91(9):1187–1192
Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusions and deferoxamine. Hematologica 89(10):1187–1193
Vermylen C (2008) What is new in iron overload? Eur J Pediatr 167(4):377–381
Telfer P, Coen PG, Christou S et al (2006) Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Haematologica 91(9):1187–1192
Brittenham GM, Griffith PM, Nienhuis AW et al (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331(9):567–573
Bajoria R, Chatterjee R (2009) Current perspectives of fertility and pregnancy in thalassemia. Hemoglobin 33(Suppl 1):S131–S135
Zafari M, Kosaryan M (2014) Marriage and child bearing in patients with transfusion-dependent thalassemia major. J Obstet Gynaecol Res 40(8):1978–1982
Chatterjee R, Katz M (2000) Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clin Endocrinol (Oxf) 53:33–42
Al-Rimawi HS et al (2005) Hypothalamic-pituitarygonadal function in adolescent females with betathalassemia major. Int J Gynaecol Obstet 90:44–47
Cisternino M, Manzoni SM, Coslovich E, Autelli M (1998) Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab 11(Suppl 3):885–890
Haghpanah S, Nasirabadi S, Ghaffarpasand F, Karami R, Mahmoodi M, Parand S, Karimi M (2013) Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire. Sao Paulo Med J 131(3):166–172
Khani H, Majdi MR, Marzabadi EA, Montazeri A, Ghorbani A, Ramezani M (2012) Quality of life of Iranian beta-thalassaemia major patients living on the southern coast of the Caspian Sea. East Mediterr Health J 18(5):539–545
Borgna-Pignatti C (2010) The life of patients with thalassemia major. Haematologica 95(3):345–348
Mancuso A, Giacobbe A, De Vivo A, Ardita FV, Meo A (2008) Pregnancy in patients with beta-thalassaemia major: maternal and foetal outcome. Acta Haematol 119(1):15–17
Origa R, Piga A, Quarta G, Forni GL, Longo F, Melpignano A, Galanello R (2010) Pregnancy and β-thalassemia: an Italian multicenter experience. Haematologica 95(3):376–381
Kumar RM, Rizk DE, Khuranna A (1997) β-Thalassemia major and successful pregnancy. J Reprod Med 42:294–298